Rankings
▼
Calendar
ZYME Q4 2025 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena
ZYME
Zymeworks Inc.
$2B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
-91.9% YoY
Gross Profit
$824,000
32.8% margin
Operating Income
-$44M
-1755.5% margin
Net Income
-$41M
-1638.5% margin
EPS (Diluted)
$-0.55
QoQ Revenue Growth
-90.9%
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$18.9B
Stock-Based Comp.
-$3.4B
Balance Sheet
Total Assets
$347M
Total Liabilities
$78M
Stockholders' Equity
$269M
Cash & Equivalents
$41.2B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$31M
-91.9%
Gross Profit
$824,000
$31M
-97.3%
Operating Income
-$44M
-$22M
-98.7%
Net Income
-$41M
-$24M
-75.3%
Revenue Segments
Upfront Fee
$18M
100%
← FY 2025
All Quarters